Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The nature of antiplatelet activity in antilymphoblast ALG--with special reference to cross-reacting antibody, immunochemical characterization, and Coombs' positive thrombocytopenia in ALG-treated renal recipients.

× No keyword cloud information.

18 in total

1. Platelet changes following clinical and experimental hepatic homotransplantation.

Authors: D E Hutchison; E Genton; K A Porter; P M Daloze; C Huguet; L Brettschneider; C G Groth; T E Starzl
Journal: Arch Surg Date: 1968-07

2. Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients.

Authors: K M Simpson; D L Bunch; H Amemiya; H J Boehmig; C B Wilson; F J Dixon; A J Coburg; W E Hathaway; G R Giles; T E Starzl
Journal: Surgery Date: 1970-07 Impact factor: 3.982

3. Antibody localization in horse, rabbit, and goat antilymphocyte sera.

Authors: N Kashiwagi; D Sherer; C M Townsend; R Jacobs; K Ono; B Kapur; T E Starzl
Journal: Surgery Date: 1970-05 Impact factor: 3.982

4. Improvements in the preparation of heterologous antilymphocyte globulin with special reference to absorption and diethylaminoethyl cellulose batch production.

Authors: N Kashiwagi; C G Groth; J R Amend; L Gecelter; H Blanchard; T E Starzl
Journal: Surgery Date: 1969-03 Impact factor: 3.982

5. Antihuman lymphoblast globulin.

Authors: J S Najarian; R L Simmons; H Gewurz; A Moberg; F Merkel; G E Moore
Journal: Fed Proc Date: 1970 Jan-Feb

6. The comparative in vitro and in vivo activity of antilymphocyte serum raised by immunization with thymic, splenic, and lymph node lymphocytes.

Authors: K Ono; P Bell; N Kashiwagi; T E Starzl
Journal: Surgery Date: 1969-10 Impact factor: 3.982

7. Measurement of antiplatelet activity of antilymphocyte sera based on the inhibition of 5-hydroxytryptamine uptake by blood platelets.

Authors: P P Kamoun; J Hamburger
Journal: Transplantation Date: 1970-07 Impact factor: 4.939

The nature of antiplatelet activity in antilymphoblast ALG--with special reference to cross-reacting antibody, immunochemical characterization, and Coombs' positive thrombocytopenia in ALG-treated renal recipients.

1. Platelet changes following clinical and experimental hepatic homotransplantation.

2. Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients.

3. Antibody localization in horse, rabbit, and goat antilymphocyte sera.

4. Improvements in the preparation of heterologous antilymphocyte globulin with special reference to absorption and diethylaminoethyl cellulose batch production.

5. Antihuman lymphoblast globulin.

6. The comparative in vitro and in vivo activity of antilymphocyte serum raised by immunization with thymic, splenic, and lymph node lymphocytes.

7. Measurement of antiplatelet activity of antilymphocyte sera based on the inhibition of 5-hydroxytryptamine uptake by blood platelets.

8. Cross-reactivity studies of horse, goat and rabbit anti-lymphocyte globulin.

9. The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions.

10. Anti-serum to cultured human lymphoblasts: preparation, purification and immunosuppressive properties in man.

1. The mechanism behind the effect of ALG on platelets in vivo.